| 1 |
Chimeric synthetic peptides as antigens for detection of antibodies to Trypanosoma cruzi
Marin MH, Spengler IH, Martinez GR, Pena LP
Biochemical and Biophysical Research Communications, 339(1), 89, 2006 |
| 2 |
Study of the peptide length and amino acid specific substitution in the antigenic activity of the chimeric synthetic peptides, containing the p19 core and gp46 envelope proteins of the HTLV-I virus
Marin MH, Rodriguez-Tanty C, Higginson-Clarke D, Bocalandro YM, Pena LP
Biochemical and Biophysical Research Communications, 336(3), 983, 2005 |
| 3 |
Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus
Marin MH, Penton PC, Bocalandro YM, Pena LP, Navarro JD, Lopez LJG
Biochemical and Biophysical Research Communications, 289(1), 1, 2001 |
| 4 |
Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-Cell leukemia virus type II
Marin MH, Penton PC, Bocalandro YM, Pena LP, Navarro JD, Lopez LJG
Biochemical and Biophysical Research Communications, 289(1), 7, 2001 |
| 5 |
Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation
Hernandez M, Selles ME, Pena LP, Gomez I, Melchor A
Biochemical and Biophysical Research Communications, 276(3), 1085, 2000 |
